That is necessary, because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we have to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental process (black sea). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was a breakthrough almost nobody saw. However it's going to have extensive implications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment chances in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (future report review). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back possibly substantially prior to going higher - jeff brown market predictions. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. last year. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so lots of fantastic private business on the edge of hitting the public markets And I have actually been working on a brand-new method for you to invest even prior to these business go public.
This chance has actually been building over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to reserve your spot totally free.
Emma Walsh here, managing editor of the Diary. Routine Diary readers understand that tech isn't our typical beat (biotech stocks jeff brown). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we know (united states). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid development and producing unbelievable opportunities for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. biotech stocks jeff brown. However in spite of what many readers may believe, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (exponential growth). Losing two months of manufacturing and sales really affects how many 5G devices are offered in the calendar year. When you consider all of that, offering 250 million systems is exceptional. More notably, the delays triggered by the pandemic created a lot of bottled-up demand. Which demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - brownstone research. And that's not my only 5G forecast When I've spoken about 5G in the past, I've explained its 3 different stages.
In Phase 2, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Phase Three, 5G services begin to be offered (jeff brown biotech stock pick for 2020). That's when we begin to see applications operating on 5G networks. Believe of things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase 3 by this summer. This starts something of a virtuous cycle: The majority of individuals don't truly care about the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment opportunities going forward will be massive. Stepping far from 5G, the next essential technology I predict in 2021 is CRISPR genetic modifying. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not function properly. CRISPR utilizes a similar concept however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For years, CRISPR was primarily a specific niche technology that wasn't well understood. And during that time, there were actually only three companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This entire industry is successfully a greenfield chance.
There's space for lots of companies to exist in this space. exponential tech investor. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can precisely forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary due to the fact that the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error process. And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced using this innovation. This was among those breakthroughs that almost nobody discovered. But it's going to have extensive ramifications for treating illness. And, of course, there will be a lot of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly substantially prior to going greater. I've been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin - jeff brown genome sequencing. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. jeff brown 2021 stock predictions. Mass, Mutual is a 150-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we could not independently verify this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like capability to pick winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an outstanding point of view on the marketplace. He's always on the hunt for new chances, and he shares a lot of his finest choices in the Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully predicted some of the most significant economic events of the past 20 years. Although he does not appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best every time, but Jeff Brown's accurate forecasts have actually made him legions of dedicated fans. That says a lot about his ability. The Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study provides numerous research services with a large variety of specializations - white house.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - biotech stock. On its website, Brownstone says its mission is to offer retail investors with professional-grade research: "For too long, the very best financial investment research has actually not been available to individual investors. It has actually been generally reserved for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown 2021 stock predictions. The objective of Brownstone Research study is to make that sort of proprietary research study offered to any investors looking to get an edge in the markets. The objective is easy to deliver special and successful investment research study discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise works as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you know even a bit about the market, you know that he has a credibility as a King Midas of sorts. jeff brown market predictions. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown believes S.A.V. tech predictions. could be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two innovative innovations: expert system and electric vehicles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing short of the automobile market's Holy Grail. As you know, electrical automobiles and self-driving cars and truck stocks have actually been big this year, but the Wall Street device has been huge on buzz without much tangible result. In spite of an extreme boost in competitors over the previous few years, Brown still believes Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transportation. Essentially, this innovation would permit you to lease your car as a self-governing, self-driving taxi when you're not utilizing it. You simply leave the cars and truck and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant piece of the revenues. It sounds ridiculous, but it could be closed than you think.